MAP2K1 and acute lymphoblastic leukemia: Activation of BECN1, a key autophagy inducer, is required for the DEX-dependent cell death in ALL (42) and for a sensitization of DEX-resistant ALL cells to obatoclax (163, 164) and MEK1/2 inhibitor (165).